DYN logo

Dyne Therapeutics (DYN) Free Cash Flow

Annual FCF

-$188.89 M
-$32.17 M-20.53%

31 December 2023

DYN Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

-$74.88 M
-$19.16 M-34.38%

30 September 2024

DYN Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

-$244.42 M
-$24.11 M-10.95%

30 September 2024

DYN TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

DYN Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-20.5%-47.5%-33.2%
3 y3 years-296.3%-169.0%-114.6%
5 y5 years-4294.8%--

DYN Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-296.3%at low-169.0%+4.9%-114.6%at low
5 y5 years-4294.8%at low-916.2%+4.9%-3159.4%at low
alltimeall time-4294.8%at low-916.2%+4.9%-3159.4%at low

Dyne Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$74.88 M(+34.4%)
-$244.42 M(+10.9%)
June 2024
-
-$55.73 M(-29.2%)
-$220.31 M(-0.1%)
Mar 2024
-
-$78.73 M(+124.4%)
-$220.48 M(+16.7%)
Dec 2023
-$188.89 M(+20.5%)
-$35.09 M(-30.9%)
-$188.89 M(+2.9%)
Sept 2023
-
-$50.77 M(-9.2%)
-$183.51 M(+4.0%)
June 2023
-
-$55.89 M(+18.6%)
-$176.43 M(+16.3%)
Mar 2023
-
-$47.14 M(+58.7%)
-$151.71 M(-3.2%)
Dec 2022
-$156.71 M
-$29.71 M(-32.0%)
-$156.71 M(-0.2%)
Sept 2022
-
-$43.69 M(+40.2%)
-$157.06 M(+11.2%)
June 2022
-
-$31.17 M(-40.2%)
-$141.20 M(-10.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$52.14 M(+73.5%)
-$156.92 M(+27.4%)
Dec 2021
-$123.18 M(+158.4%)
-$30.06 M(+8.0%)
-$123.18 M(+8.2%)
Sept 2021
-
-$27.83 M(-40.6%)
-$113.88 M(+16.1%)
June 2021
-
-$46.89 M(+154.8%)
-$98.09 M(+67.5%)
Mar 2021
-
-$18.40 M(-11.4%)
-$58.57 M(+22.9%)
Dec 2020
-$47.67 M(+253.6%)
-$20.76 M(+72.4%)
-$47.67 M(+77.1%)
Sept 2020
-
-$12.04 M(+63.4%)
-$26.91 M(+81.0%)
June 2020
-
-$7.37 M(-1.7%)
-$14.87 M(+98.3%)
Mar 2020
-
-$7.50 M
-$7.50 M
Dec 2019
-$13.48 M(+213.7%)
-
-
Dec 2018
-$4.30 M
-
-

FAQ

  • What is Dyne Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Dyne Therapeutics?
  • What is Dyne Therapeutics annual FCF year-on-year change?
  • What is Dyne Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Dyne Therapeutics?
  • What is Dyne Therapeutics quarterly FCF year-on-year change?
  • What is Dyne Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Dyne Therapeutics?
  • What is Dyne Therapeutics TTM FCF year-on-year change?

What is Dyne Therapeutics annual free cash flow?

The current annual FCF of DYN is -$188.89 M

What is the all time high annual FCF for Dyne Therapeutics?

Dyne Therapeutics all-time high annual free cash flow is -$4.30 M

What is Dyne Therapeutics annual FCF year-on-year change?

Over the past year, DYN annual free cash flow has changed by -$32.17 M (-20.53%)

What is Dyne Therapeutics quarterly free cash flow?

The current quarterly FCF of DYN is -$74.88 M

What is the all time high quarterly FCF for Dyne Therapeutics?

Dyne Therapeutics all-time high quarterly free cash flow is -$7.37 M

What is Dyne Therapeutics quarterly FCF year-on-year change?

Over the past year, DYN quarterly free cash flow has changed by -$24.11 M (-47.50%)

What is Dyne Therapeutics TTM free cash flow?

The current TTM FCF of DYN is -$244.42 M

What is the all time high TTM FCF for Dyne Therapeutics?

Dyne Therapeutics all-time high TTM free cash flow is -$7.50 M

What is Dyne Therapeutics TTM FCF year-on-year change?

Over the past year, DYN TTM free cash flow has changed by -$60.91 M (-33.19%)